About the Event
In this installment of Internal Medicine Grand Rounds presented by the Department of Internal Medicine and the Livestrong Cancer Institutes, Jennifer Haas, M.D., presents “Care-Based Interventions to Improve Cancer Screening and Prevention.” Haas is a professor of medicine at Harvard Medical School and a professor of social and behavioral sciences at Harvard’s T.H. Chan School of Public Health.
Please register by 5 p.m. on Tuesday, March 21.
For more information, contact Lyndsey Loughran.
Objectives
By the end of this presentation, the audience participant should be able to:
- Identifying potential targets for intervention from observational data
- Develop research strategies for interventions to improve cancer screening and prevention
- Discuss examples of interventions in practice
Target Audience
- Primary: Department of Internal Medicine faculty
- Secondary: Department of Internal Medicine residents and health care team members
Attributes/Competencies
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care, Medical Knowledge, Practice-based Learning and Improvement, Professionalism, Systems-based Practice
- IOM: Provide patient-centered care, Work in interdisciplinary teams, Employ evidence-based practice, Apply quality improvement
- IECC: Interprofessional Communication, Teams and Teamwork
Speaker Disclosure
Jennifer Haas, M.D., speaker for this educational activity, has no relevant relationship(s) with ineligible companies to disclose.
Planner Disclosure
Parker Hudson, M.D., MPH, FACP; Beth Nelson, M.D.; Kirsten Gibbs Nieto, M.D.; Snehal Patel, M.D.; Chris Moreland, M.D., MPH; Ollieta Nicholas, MBA, FACHE; and Lyndsey Loughran, MHQS, planners for this educational activity, have no relevant financial relationships with ineligible companies to disclose.
Annie Feagins, M.D., received grants/research funding from Corevitas, Takeda and Arena.
Yan Liu, M.D., Ph.D., received royalties and is a patent holder for G1 Therapeutics.
Kevin Hackshaw, M.D., is a stock shareholder of Pfizer, Merck and Exagen.
Anokhi Jambusaria-Pahlajani, M.D., MSCE, is a consultant with Regeneron Pharmaceuticals, Inc.
Brian Lee, M.D., is on the advisory board of HealthMap Solution Inc.
The CME Advisory Committee, reviewers of this educational activity, have no relevant relationships with ineligible companies to disclose.
All of the relevant financial relationships listed have been mitigated.
Accreditation Statement
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.